ClinVar Miner

Submissions for variant NM_000518.5(HBB):c.92+5G>T (rs33915217)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000030005 SCV000052660 pathogenic Beta thalassemia major 2011-08-18 criteria provided, single submitter curation Converted during submission to Pathogenic.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000505898 SCV000601329 pathogenic not provided 2016-09-07 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000506613 SCV000603942 pathogenic not specified 2018-08-06 criteria provided, single submitter clinical testing The HBB c.92+5G>T variant (rs33915217), also known as IVS-I-5 (G->T), has been reported in multiple patients with severe beta(+) thalassemia (Atweh 1987, HbVar database and references therein). Functional studies indicate that the variant causes aberrant splicing of the HBB RNA and reduction of full-length mRNA transcripts (Atweh 1987). The variant is listed as pathogenic in ClinVar (Variation ID: 15448), and observed once in the Genome Aggregation Database (1/245966 alleles). Computational algorithms (GeneSplicer, Human Splicing Finder, MaxEntScan, MutationTaster, NetGene2, NNSplice, SpliceSiteFinder-like) predict that the variant reduces the efficiency of the nearby canonical splice donor, consistent with functional studies. Based on the above information, the variant is classified as pathogenic. References: Link to HbVar database for IVS-I-5 (G->T): Atweh G et al. A new mutation in IVS-1 of the human beta globin gene causing beta thalassemia due to abnormal splicing. Blood. 1987; 70(1):147-51.
OMIM RCV000016706 SCV000036976 pathogenic Beta-plus-thalassemia 1989-03-01 no assertion criteria provided literature only
Counsyl RCV000984182 SCV001132216 pathogenic beta Thalassemia 2015-09-03 no assertion criteria provided clinical testing
The ITHANET community portal, The Cyprus Institute of Neurology and Genetics RCV000984182 SCV001244507 pathogenic beta Thalassemia 2019-11-25 no assertion criteria provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.